Allen Holding’s ImmunityBio IBRX Stock Holding History

Allen Holding’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.02M	Hold	687,571	–	–	0.59%	9
2026 Q1	$5.27M	Hold	687,571	–	–	0.52%	9
2025 Q4	$1.36M	Hold	687,571	–	–	0.13%	9
2025 Q3	$1.69M	Hold	687,571	–	–	0.16%	9
2025 Q2	$1.82M	Hold	687,571	–	–	0.18%	10
2025 Q1	$2.07M	Hold	687,571	–	–	0.22%	13
2024 Q4	$1.76M	Hold	687,571	–	–	0.19%	13
2024 Q3	$2.56M	Hold	687,571	–	–	0.28%	11
2024 Q2	$4.35M	Hold	687,571	–	–	0.54%	9
2024 Q1	$3.69M	Hold	687,571	–	–	0.46%	11
2023 Q4	$3.45M	Hold	687,571	–	–	0.48%	11
2023 Q3	$1.16M	Hold	687,571	–	–	0.16%	16
2023 Q2	$1.91M	Hold	687,571	–	–	0.26%	14
2023 Q1	$1.25M	Hold	687,571	–	–	0.18%	15
2022 Q4	$3.49M	Hold	687,571	–	–	0.49%	10
2022 Q3	$3.42M	Hold	687,571	–	–	0.54%	10
2022 Q2	$2.56M	Hold	687,571	–	–	0.37%	13
2022 Q1	$3.86M	Hold	687,571	–	–	0.5%	13
2021 Q4	$4.18M	Hold	687,571	–	–	0.56%	13
2021 Q3	$6.7M	Hold	687,571	–	–	0.99%	10
2021 Q2	$9.82M	Buy	+687,571	New	+$11.4M	1.5%	8

Other funds holding IBRX

SAM

SEB Asset Management Stockholm $26.6B AUM

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Kercheville Advisors San Antonio, Texas $328M AUM 76.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

SSWM

Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return

LCGC

Legacy Capital Group California Los Gatos, California $332M AUM 42.15% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return

NIA

NIA Impact Advisors Berkeley, California $241M AUM 44.09% 1-Year Est. Return

Allen Holding's IBRX Position: Q2 2026 in Review

Allen Holding held its ImmunityBio (IBRX) position steady in Q2 2026 at 687,571 shares worth $6.02M. The position accounts for 0.59% of the portfolio, ranked #9.

Allen Holding first reported a position in IBRX in Q2 2021 and has held it in 21 quarters since. The position peaked at $9.82M in Q2 2021. 169 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

Allen Holding held 687,571 shares of ImmunityBio worth $6.02M as of Q2 2026.
Allen Holding left its ImmunityBio share count unchanged in Q2 2026.
ImmunityBio made up 0.59% of Allen Holding's portfolio in Q2 2026, its #9 holding.
Allen Holding first reported a position in ImmunityBio in Q2 2021 and has held it in 21 quarters since.
Allen Holding's ImmunityBio position peaked at $9.82M in Q2 2021.
169 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Allen Holding's 13F filing for Q2 2026, filed 5 Aug 2026.